The circulation and traceability system of traditional Chinese medicine of the Ministry of Commerce strives to cover the whole country by the end of the 12th Five Year Plan

In 2013, the Ministry of Commerce selected seven provinces of Gansu, Yunnan, Jilin, Hunan, Henan, Jiangxi and Guangdong to continue to promote the construction of the traceability system for the circulation of traditional Chinese medicine and strive to achieve the goal of covering the whole country by the end of the 12th Five Year Plan Since 2012, the Ministry of Commerce has made use of information technology to electronic the system of asking for certificates, asking for tickets, purchasing and selling standing books, forming a circulation traceability system of traditional Chinese medicine with "known source, traceable destination, traceable quality and accountability", so as to improve the circulation of traditional Chinese medicine To ensure the people's life and health through the ability of quality assurance and the level of modernization At present, in Baoding, Bozhou, Yulin and Chengdu, four pilot cities in 2012, positive progress has been made in the construction of the traceability system for the circulation of traditional Chinese medicine The system and standard system have been initially established The development and construction of the central traceability management platform and unified software have been completed It is expected that 8530 operators inside and outside the market of traditional Chinese medicine, 35 planting bases and 195 Chinese medicine will be covered by the end of March next year The target of the pharmaceutical enterprises, 338 pharmaceutical enterprises, 20 hospitals and 233 pharmacies The reporter also learned from the Ministry of commerce that in recent years, China's pharmaceutical circulation industry has accelerated the pace of merger, reorganization, transformation and upgrading According to incomplete statistics, since 2011, there have been 329 mergers and reorganizations carried out by drug distribution enterprises nationwide, involving 10.1 billion yuan; there have been 76 mergers and reorganizations carried out by 15 drug distribution listed companies, involving 7.5 billion yuan, ranking first in the number of mergers and reorganizations of pharmaceutical listed companies for three consecutive years The merger and reorganization activities integrate the existing drug circulation resources, accelerate the application of information technology and modern medicine logistics technology, drive the transformation and upgrading of small and medium-sized enterprises, improve the industry concentration, and play an important role in the healthy development of the whole industry